CPRIT approved almost $100 million in grants to advance the fight against cancer in Texas
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
-
-
NIH launched research network to evaluate emerging cancer screening technologies
On Feb. 21, 2024, the National Institutes of Health (NIH) announced it had launched a clinical trials network…
-
Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
-
Global cancer burden growing, amidst mounting need for services
On Feb. 1, 2024, the World Health Organization (WHO) announced that new estimates on IARCﾒs Global Cancer Observatory…
-
HPV vaccine study found zero cases of cervical cancer among women vaccinated before age 14
On Jan. 25, 2024, an historic study out of Scotland showed the real-world impact of vaccines against the…
-
Health effects associated with exposure to secondhand smoke: a Burden of Proof study
On Jan. 9, 2024, the Institute for Health Metrics and Evaluation (HHMI) reported that despite a gradual decline…
-
Molecular jackhammers’ ‘good vibrations’ eradicate cancer cells
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
-
W. Kimryn Rathmell, M.D., Ph.D., began work as 17th director of the National Cancer Institute
On Dec. 18, 2023, W. Kimryn Rathmell, M.D., Ph.D., began work as the 17th director of the National…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Therapeutics
Alberta researchers revealed full structure of ‘ancient genetic parasite’ implicated in human diseases
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…
-
Pfizer completed acquisition of Seagen for $43 billion
On Dec. 14, 2023, Pfizer announced it had completed the acquisition of Seagen, a global biotechnology company based…
-
Using next-gen CRISPR tool, Gladstone scientists created unprecedented molecular map of human immune response
On Dec. 13, 2023, in a study of historic scale, scientists at Gladstone Institutes announced that they had…
-
University of Missouri research reactor announced commercial shipments of radioisotope for cancer treatment
On Dec. 6, 2023, the University of Missouri Research Reactor (MURR) announced they had completed its first commercial…
-
Biotechnology | Diagnostics | Disease | Genomics | Neurology | Oncology | Therapeutics
World’s largest genetic project unveiled incredible new data
On Nov. 30, 2023, in a momentous landmark for medical research, UK Biobank announced that it had unveiled…
-
FDA approved first therapy for rare type of non-cancerous tumorsﾠ
On Nov. 27, 2023, the U.S. Food and Drug Administration approved SpringWorks’ Ogsiveo (nirogacestat) tablets for adult patients…
-
CPRIT invested $63 million to bring innovative researchers and companies to Texas
On Nov. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced that it had approved…
-
Abbott received FDA approval for HPV test to run on Alinity m family of diagnostic assays
On Nov. 2, 2023, Abbott announced that it had received U.S. Food and Drug Administration (FDA) approval for…
-
Biotechnology | Diagnostics | Medical Device | Neurology | Non-Profit Research | Stem Cell | Therapeutics
California’s Stem Cell Agency invested more than $42.1 million in translational-stage research
On Oct. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $42.1 million to fund various translational…
-
FDA approved new therapy for rare form of blood cancers called myelodysplastic syndromes
On Oct. 24, 2023, the U.S. Food and Drug Administration approved Servier Pharmaceuticals’ Tibsovo (ivosidenib) for the treatment…
-
Purdue named new pediatric cancer research center for the late Tyler Trent
On Oct. 14, 2023, Purdue University ensured that the memory of the former graduate and devoted Boilermaker football…
-
California became first U.S. state to ban red dye No. 3
On Oct. 7, 2023, California became the first state to ban four chemicals used in well-known candies and…
-
FDA granted first marketing authorization for DNA test to assess predisposition for dozens of cancer types
On Sept. 29, 2023, the U.S. Food and Drug Administration (FDA) granted Invitae de novo marketing authorization for…
-
New cancer diagnoses fell abruptly early in the COVID-19 pandemic according to Annual Report to the Nation
On Sept. 27, 2023, the U.S. Centers for Disease Control and Prevention (CDC) reported that new diagnoses of…
-
NIH unveiled comprehensive proteogenomic dataset to help cancer researchers unravel molecular mysteries
On Aug. 14, 2023, the National Institute of Health announced that it had released a comprehensive dataset that…
-
Henrietta Lacks’ family settled lawsuit with biotech company that used her cells without consent
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
-
Biotechnology | FDA | Oncology | Radiology | Stem Cell
U.S. FDA approves cell therapy for patients with blood cancers to reduce risk of infection after stem cell transplantation
On Apr. 17, 2023, the U.S. Food and Drug Administration (FDA) approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially…
-
Biotechnology | Diagnostics | Medicine | NIH | Oncology | Radiology | Therapeutics | Women's Health
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
-
Thermo Fisher Scientific opened cell therapy facility at University of California, San Francisco
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
-
Biotechnology | Diagnostics | NIH | Oncology | Radiology
Blood test identified acute myeloid leukemia patients at greater risk for relapse after bone marrow transplant
On Mar. 7, 2023, researchers at the National Institutes of Health reported the benefits of screening adult patients…
-
Veklury (Remdesivir) reduced risk of mortality in hospitalized COVID-19 patients across all variants in real world study
On Feb. 21, 2023, Gilead Sciences announced positive data from three retrospective real-world studies which demonstrated that initiation…
-
CPRIT approved $12 million to bring top-flight cancer researchers to Lone Star State
On Feb. 15, 2023, the Cancer Prevention and Research Institute of Texas (CPRIT) announced a major step forward…
